Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.105 USD | -1.67% | -4.49% | -5.77% |
May. 09 | Enfusion Shares Fall Despite Higher Q1 Results | MT |
May. 09 | Transcript : Enfusion, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 206M | Sales 2025 * | 243M | Capitalization | 842M |
---|---|---|---|---|---|
Net income 2024 * | 10M | Net income 2025 * | 22M | EV / Sales 2024 * | 3.82 x |
Net cash position 2024 * | 55.52M | Net cash position 2025 * | 92.17M | EV / Sales 2025 * | 3.08 x |
P/E ratio 2024 * |
156
x | P/E ratio 2025 * |
63
x | Employees | 1,102 |
Yield 2024 * |
0.06% | Yield 2025 * |
-
| Free-Float | 39.33% |
Latest transcript on Enfusion, Inc.
1 day | -2.65% | ||
1 week | -5.75% | ||
Current month | -3.11% | ||
1 month | -5.65% | ||
3 months | +6.12% | ||
6 months | -4.35% | ||
Current year | -7.01% |
Managers | Title | Age | Since |
---|---|---|---|
Oleg Movchan
FOU | Founder | 50 | 05-12-31 |
Bradley Herring
DFI | Director of Finance/CFO | 54 | 22-12-18 |
Dan Groman
CTO | Chief Tech/Sci/R&D Officer | 35 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen DeRose
BRD | Director/Board Member | 63 | 21-12-06 |
Brad Bernstein
BRD | Director/Board Member | 57 | 20-12-31 |
Director/Board Member | 63 | 19-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +9.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 9.15 | -1.19% | 236 547 |
24-05-09 | 9.26 | -5.22% | 589,326 |
24-05-08 | 9.77 | +0.41% | 280,145 |
24-05-07 | 9.73 | -0.51% | 259,873 |
24-05-06 | 9.78 | +2.19% | 421,891 |
Delayed Quote Nyse, May 10, 2024 at 10:32 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.01% | 842M | |
+9.86% | 3,064B | |
+7.91% | 83.88B | |
+5.02% | 77.63B | |
-13.42% | 53.97B | |
+21.67% | 47.08B | |
-24.07% | 46.81B | |
+21.32% | 43.34B | |
+61.93% | 37.9B | |
-9.59% | 24.85B |
- Stock Market
- Equities
- ENFN Stock